14 results

  • ciclopirox olamine

    (Ciclopirox Olamine)
    Padagis Israel Pharmaceuticals Ltd
    Ciclopirox Olamine Topical Suspension 0.77% is indicated for the topical treatment of dermal infections such as tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and tinea versicolor, caused by specific fungi including *Trichophyton*, *Epidermophyton*, *Microsporum*, *Candida*, and *Malassezia* species.

  • clindamycin and benzoyl peroxide

    (clindamycin and benzoyl peroxide)
    Padagis Israel Pharmaceuticals Ltd
    Clindamycin and benzoyl peroxide topical gel, 1%/5%, is indicated for the topical treatment of acne vulgaris.

  • clindamycin phosphate and benzoyl peroxide

    (Clindamycin Phosphate and Benzoyl Peroxide)
    Padagis Israel Pharmaceuticals Ltd
    Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/3.75%, is indicated for the topical treatment of acne vulgaris in patients aged 12 and older.

  • clindamycin phosphate and benzoyl peroxide

    (Clindamycin Phosphate, Benzoyl Peroxide)
    Padagis Israel Pharmaceuticals Ltd
    Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%, is indicated for the topical treatment of acne vulgaris in patients aged 12 years and older.

  • fluocinolone acetonide

    (fluocinolone acetonide)
    Padagis Israel Pharmaceuticals Ltd
    Fluocinolone Acetonide Topical Oil, 0.01% is indicated for topical treatment of atopic dermatitis in adults and moderate to severe cases in pediatric patients aged 3 months and older for up to 4 weeks. Safety in children under 3 months is not established.

  • fluocinolone acetonide

    (Fluocinolone acetonide)
    Padagis Israel Pharmaceuticals Ltd
    Fluocinolone Acetonide Topical Oil, 0.01% is indicated for the treatment of scalp psoriasis in adult patients.

  • fluocinonide

    (fluocinonide)
    Padagis Israel Pharmaceuticals Ltd
    Fluocinonide Gel USP, 0.05% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.

  • flurandrenolide

    (Flurandrenolide)
    Padagis Israel Pharmaceuticals Ltd
    Flurandrenolide Lotion USP, 0.05% is indicated for relieving inflammation and itching associated with corticosteroid-responsive dermatoses.

  • ketoconazole

    (ketoconazole)
    Padagis Israel Pharmaceuticals Ltd
    Ketoconazole foam, 2% is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients aged 12 and older. Its safety and efficacy for treating fungal infections are not established.

  • mesalamine

    (Mesalamine)
    Padagis Israel Pharmaceuticals Ltd
    Mesalamine rectal suspension enema is indicated for treating active mild to moderate distal ulcerative colitis, proctosigmoiditis, or proctitis in adults.